BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21925010)

  • 1. Therapeutic approaches to patients with mucous membrane pemphigoid.
    Kourosh AS; Yancey KB
    Dermatol Clin; 2011 Oct; 29(4):637-41. PubMed ID: 21925010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in mucous membrane pemphigoid.
    Daniel E; Thorne JE
    Curr Opin Ophthalmol; 2008 Jul; 19(4):292-7. PubMed ID: 18545009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for patients with refractory mucous membrane pemphigoid.
    Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
    Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide therapy for cicatricial pemphigoid.
    Duong DJ; Moxley RT; Kellman RM; Pincus SH; Gaspari AA
    J Am Acad Dermatol; 2002 Aug; 47(2 Suppl):S193-5. PubMed ID: 12140460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking responsibility for complex medical dermatology patient management.
    Zone JJ
    Arch Dermatol; 2011 Jul; 147(7):850. PubMed ID: 21768485
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of mucous membrane pemphigoid and pemphigus.
    Knudson RM; Kalaaji AN; Bruce AJ
    Dermatol Ther; 2010; 23(3):268-80. PubMed ID: 20597945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross AH; Jaycock P; Cook SD; Dick AD; Tole DM
    Br J Ophthalmol; 2009 Apr; 93(4):421-2, 548. PubMed ID: 19321473
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
    Shetty S; Ahmed AR
    J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucous membrane pemphigoid: nasal and laryngeal manifestations.
    Whiteside OJ; Martinez Devesa P; Ali I; Capper JW
    J Laryngol Otol; 2003 Nov; 117(11):885-8. PubMed ID: 14670151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mucous membrane pemphigoid with rituximab.
    Heelan K; Walsh S; Shear NH
    J Am Acad Dermatol; 2013 Aug; 69(2):310-1. PubMed ID: 23866864
    [No Abstract]   [Full Text] [Related]  

  • 13. Colchicine in the management of mucous membrane pemphigoid.
    Chaidemenos G; Sidiropoulos T; Katsioula P; Koussidou-Eremondi T
    Dermatol Ther; 2011; 24(4):443-5. PubMed ID: 21910802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to "Treatment of mucous membrane pemphigoid with rituximab".
    Ahmed AR; Shetty S
    J Am Acad Dermatol; 2013 Aug; 69(2):311-2. PubMed ID: 23866865
    [No Abstract]   [Full Text] [Related]  

  • 15. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of ocular disease in mucous membrane pemphigoid.
    Brunner M; Lacoste KJ; Bernauer W
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):331-4. PubMed ID: 24771161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucous membrane pemphigoid: management of advanced ocular disease with intravenous cyclophosphamide and amniotic membrane transplantation.
    Yesudian PD; Armstrong S; Cawood JI; Allan RB; Mendelsohn SS; Kaye SB
    Br J Dermatol; 2005 Sep; 153(3):692-4. PubMed ID: 16120180
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.
    John H; Whallett A; Quinlan M
    Eye (Lond); 2007 Nov; 21(11):1434-5. PubMed ID: 17693996
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients.
    Rauz S; Maddison PG; Dart JK
    Ophthalmology; 2005 Jul; 112(7):1268-74. PubMed ID: 15921743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid.
    Schulz S; Deuster D; Schmidt E; Bonsmann G; Beissert S
    Int J Dermatol; 2011 Sep; 50(9):1129-31. PubMed ID: 22126878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.